Literature DB >> 13816307

A clinical trial of penta-erythritol tetranitrate, a khellin derivative (recordil), and iproniazid in angina of effort.

H A DEWAR, A R HORLER, D J NEWELL.   

Abstract

Entities:  

Keywords:  ANGINA PECTORIS/therapy; IPRONIAZID/therapy; KHELLIN/related compounds; NITRITES/therapy

Mesh:

Substances:

Year:  1959        PMID: 13816307      PMCID: PMC1017586          DOI: 10.1136/hrt.21.3.315

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  18 in total

1.  Further observations of cardiovascular effects of pentaerythritol tetranitrate in animals and man.

Authors:  T WINSOR; C C SCOTT
Journal:  Am Heart J       Date:  1955-03       Impact factor: 4.749

2.  Assay of anti-anginal agents. I. A curve analysis with multiple control periods.

Authors:  S L COLE; H KAYE; G C GRIFFITH
Journal:  Circulation       Date:  1957-03       Impact factor: 29.690

3.  [Serendipity and angina pectoris; preliminary report on a therapeutic finding].

Authors:  T CESARMAN
Journal:  Arch Inst Cardiol Mex       Date:  1957 Sep-Oct

4.  Nitroglycerin and other nitrites in the treatment of angina pectoris; comparison of six preparations and four routes of administration.

Authors:  J E RISEMAN; G E ALTMAN; S KORETSKY
Journal:  Circulation       Date:  1958-01       Impact factor: 29.690

5.  Trial of drugs for angina of effort: the oral use of pentaerythritol tetranitrate, including a comparison with aminophylline and dihydroxypropyltheophylline.

Authors:  R FIFE; G HOWITT; J STEVENSON
Journal:  Scott Med J       Date:  1958-01       Impact factor: 0.729

6.  Rauwolfia serpentina in the treatment of angina pectoris.

Authors:  L E JANUARY; B I LEWIS; R I LUBIN; J B WILD
Journal:  Circulation       Date:  1956-08       Impact factor: 29.690

7.  Objective evaluation of coronary vasodilator drugs.

Authors:  H I RUSSEK; B L ZOHMAN; V J DORSET
Journal:  Am J Med Sci       Date:  1955-01       Impact factor: 2.378

8.  The use of pentaerythritol tetranitrate in chronic coronary insufficiency.

Authors:  H N ROSENBERG; A L MICHELSON
Journal:  Am J Med Sci       Date:  1955-09       Impact factor: 2.378

9.  [Not Available].

Authors:  P BALATRE; J MERLEN; L GRANDJEAN
Journal:  Presse Med       Date:  1949-11-19       Impact factor: 1.228

10.  Use of pentaerythritol tetranitrate (peritrate) in treatment of angina pectoris.

Authors:  R W TALLEY; O W BEARD; J F DOHERTY
Journal:  Am Heart J       Date:  1952-12       Impact factor: 4.749

View more
  12 in total

1.  Effects of continued pentaerythritol tetranitrate administration on myocardial circulation and metabolism.

Authors:  A D BENDER; F J SULLIVAN; S M HORVATH
Journal:  Experientia       Date:  1963-05-15

2.  Clinical evaluation of pheniprazine in angina pectoris.

Authors:  G SANDLER
Journal:  Br Med J       Date:  1961-03-18

3.  Iproniazid in treatment of angina of effort.

Authors:  R FIFE; G HOWITT; J STEVENSON
Journal:  Br Med J       Date:  1960-03-05

4.  Dangerous potentiation of pethidine by iproniazid, and its treatment.

Authors:  J C SHEE
Journal:  Br Med J       Date:  1960-08-13

5.  A trial of a new monoamine oxidase inhibitor in angina pectoris.

Authors:  D PHEAR; W C WALKER
Journal:  Br Med J       Date:  1960-10-01

6.  Preliminary observations on cavodil in treatment of angina pectoris.

Authors:  J MACKINNON; D E ANDERSON; G HOWITT
Journal:  Br Med J       Date:  1960-01-23

7.  To-day's Drugs.

Authors: 
Journal:  Br Med J       Date:  1963-07-13

8.  Drugs in Angina.

Authors: 
Journal:  Br Med J       Date:  1960-01-23

Review 9.  Headache-type adverse effects of NO donors: vasodilation and beyond.

Authors:  G Bagdy; P Riba; V Kecskeméti; D Chase; G Juhász
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

10.  Clinical evaluation of propatylnitrate in angina pectoris.

Authors:  G SANDLER
Journal:  Br Med J       Date:  1961-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.